Table 4.
Bioassay results.
| Microcosms | Ostracodtoxkit Test | Microtox Solid Phase Test | Ames Test | |
|---|---|---|---|---|
| Mortality (%) (Chronic Toxicity) | Growth Inhibition (%) (Chronic Toxicity) | Toxicity (TU) | Mutagenicity Ratio | |
| Control | 54.6 ± 5,1 | No data | 28.7 ± 2.9 | 14.2 |
| BS | 40.3 ± 3.2 | 44.5 ± 4.3 | 22.9 ± 2.2 | 10.5 |
| BA-C1 | 33.1 ± 3.2 | 36.5 ± 3.5 | 13.2 ± 1.3 | 7.2 |
| BA-C2 | 17.0 ± 0.9 | 20.4 ± 1.3 | 1.2 ± 0.2 | 1.2 |
Control: untreated microcosms, BS: biostimulated microcosms, BA-C1 and BA-C2: microcosms bioaugmented with the bacterial community C1 and the mixed culture C2, respectively.